Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rang in aandelen #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Aandeelprijs
$14.30
Laatst gesynchroniseerd: 2023-06-29
Marktkapitalisatie
$1.81B
Verandering (1 dag)
-2.81%
Verandering (1 jaar)
0.00%
Land
CA
Handel BELLUS Health Inc. (BLU)

Categorie

Koersgeschiedenis voor BELLUS Health Inc. (BLU)
Hoogste slotkoers: $14.62 op 2023-06-01

Laagste slotkoers: $617.12 op 2000-06-01
Koersgeschiedenis van BELLUS Health Inc. van 2000 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2023 56.80%
2022 31.13%
2021 132.06%
2020 -56.49%
2019 141.94%
2018 161.76%
2017 54.42%
2016 -72.16%
2015 -39.98%
2014 212.05%
2013 -6.93%
2012 -69.52%
2011 -61.15%
2010 -32.03%
2009 -57.70%
2008 -83.40%
2007 -89.98%
2006 82.43%
2005 -27.25%
2004 -7.64%
2003 313.71%
2002 87.44%
2001 -57.20%
2000 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.16 -12.75%
AU
$140.81 475.44%
US
$765.25 7.74%
CH